These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 17522055

  • 1. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
    Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH.
    J Biol Chem; 2007 Jul 20; 282(29):21542-50. PubMed ID: 17522055
    [Abstract] [Full Text] [Related]

  • 2. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.
    Li Y, Wang Z, Kong D, Li R, Sarkar SH, Sarkar FH.
    J Biol Chem; 2008 Oct 10; 283(41):27707-27716. PubMed ID: 18687691
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
    Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH.
    Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
    Chinnakannu K, Chen D, Li Y, Wang Z, Dou QP, Reddy GP, Sarkar FH.
    J Cell Physiol; 2009 Apr 15; 219(1):94-9. PubMed ID: 19062173
    [Abstract] [Full Text] [Related]

  • 5. Proliferative and androgenic effects of indirubin derivatives in LNCaP human prostate cancer cells at sub-apoptotic concentrations.
    Rivest P, Renaud M, Sanderson JT.
    Chem Biol Interact; 2011 Feb 01; 189(3):177-85. PubMed ID: 21111724
    [Abstract] [Full Text] [Related]

  • 6. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
    Park N, Baek HS, Chun YJ.
    PLoS One; 2015 Feb 01; 10(8):e0134760. PubMed ID: 26252009
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
    Schütz SV, Schrader AJ, Zengerling F, Genze F, Cronauer MV, Schrader M.
    PLoS One; 2011 Feb 01; 6(9):e25341. PubMed ID: 21980429
    [Abstract] [Full Text] [Related]

  • 10. EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.
    Chong ZZ, Hou J, Shang YC, Wang S, Maiese K.
    Curr Neurovasc Res; 2011 May 01; 8(2):103-20. PubMed ID: 21443457
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
    Soda M, Willert K, Kaushansky K, Geddis AE.
    Cell Signal; 2008 Dec 01; 20(12):2317-23. PubMed ID: 18804163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B.
    Endocrinology; 2004 Jun 01; 145(6):2941-9. PubMed ID: 14988390
    [Abstract] [Full Text] [Related]

  • 15. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells.
    Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C.
    J Biol Chem; 2005 Sep 30; 280(39):33558-65. PubMed ID: 16061480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD147 modulates androgen receptor activity through the Akt/Gsk-3β/β-catenin/AR pathway in prostate cancer cells.
    Fang F, Qin Y, Hao F, Li Q, Zhang W, Zhao C, Chen S, Zhao L, Wang L, Cai J.
    Oncol Lett; 2016 Aug 30; 12(2):1124-1128. PubMed ID: 27446405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.